电脑桌面
添加小米粒文库到电脑桌面
安装后可以在桌面快捷访问

关于医疗器械领域公告机构审核和评估的建议2013_473_EU

关于医疗器械领域公告机构审核和评估的建议2013_473_EU_第1页
1/9
关于医疗器械领域公告机构审核和评估的建议2013_473_EU_第2页
2/9
关于医疗器械领域公告机构审核和评估的建议2013_473_EU_第3页
3/9
RECOMMENDATIONS COMMISSION RECOMMENDATION of 24 September 2013 on the audits and assessments performed by notified bodies in the field of medical devices (Text with EEA relevance) (2013/473/EU) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, and in particular Article 292 thereof, Whereas: (1) The proper functioning of notified bodies is crucial for ensuring a high level of health and safety protection, the free movement of medical devices in the internal market, and citizens’ confidence in the regulatory system. (2) Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices ( 1 ), Council Directive 93/42/EEC of 14 June 1993 concerning medical devices ( 2 ), and Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices ( 3 ), contain certain provisions with regard to the audits, assessments and unannounced audits performed by notified bodies in the field of medical devices. (3) The interpretation of those provisions and the behaviour of notified bodies designated in the field of medical devices differ. Therefore this Recommendation should set benchmarks for assessments and unannounced audits by notified bodies and respond to the most frequent shortcomings of the current practices. (4) The Recommendation aims at ensuring that the notified body carries out a proper verification of the fulfilment of the legal requirements by the manufacturer. (5) Subject to the respective conformity assessment procedure, notified bodies perform product assessments or quality system assessments. Accordingly, it is important to dif...

1、当您付费下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身使用,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。
3、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。

碎片内容

关于医疗器械领域公告机构审核和评估的建议2013_473_EU

确认删除?
VIP
微信客服
  • 扫码咨询
会员Q群
  • 会员专属群点击这里加入QQ群
客服邮箱
回到顶部